Similar articles for PMID: 28864633

Year	Number of Results
2002	1
2012	1
2013	1
2014	3
2015	9
2016	19
2017	27
2018	26
2019	15
2020	17
2021	20
2022	18
2023	5
2024	0

1

Correlations of ¹⁸F-THK5351 PET with Postmortem Burden of Tau and Astrogliosis in Alzheimer Disease.

Harada R, Ishiki A, Kai H, Sato N, Furukawa K, Furumoto S, Tago T, Tomita N, Watanuki S, Hiraoka K, Ishikawa Y, Funaki Y, Nakamura T, Yoshikawa T, Iwata R, Tashiro M, Sasano H, Kitamoto T, Yanai K, Arai H, Kudo Y, Okamura N. Harada R, et al. J Nucl Med. 2018 Apr;59(4):671-674. doi: 10.2967/jnumed.117.197426. Epub 2017 Sep 1. J Nucl Med. 2018. PMID: 28864633 Free article.

2

Neuroimaging-pathological correlations of [¹⁸F]THK5351 PET in progressive supranuclear palsy.

Ishiki A, Harada R, Kai H, Sato N, Totsune T, Tomita N, Watanuki S, Hiraoka K, Ishikawa Y, Funaki Y, Iwata R, Furumoto S, Tashiro M, Sasano H, Kitamoto T, Kudo Y, Yanai K, Furukawa K, Okamura N, Arai H. Ishiki A, et al. Acta Neuropathol Commun. 2018 Jun 29;6(1):53. doi: 10.1186/s40478-018-0556-7. Acta Neuropathol Commun. 2018. PMID: 29958546 Free PMC article.

3

Monoamine oxidase B inhibitor, selegiline, reduces ¹⁸F-THK5351 uptake in the human brain.

Ng KP, Pascoal TA, Mathotaarachchi S, Therriault J, Kang MS, Shin M, Guiot MC, Guo Q, Harada R, Comley RA, Massarweh G, Soucy JP, Okamura N, Gauthier S, Rosa-Neto P. Ng KP, et al. Alzheimers Res Ther. 2017 Mar 31;9(1):25. doi: 10.1186/s13195-017-0253-y. Alzheimers Res Ther. 2017. PMID: 28359327 Free PMC article.

4

Dual tracer tau PET imaging reveals different molecular targets for ¹¹C-THK5351 and ¹¹C-PBB3 in the Alzheimer brain.

Chiotis K, Stenkrona P, Almkvist O, Stepanov V, Ferreira D, Arakawa R, Takano A, Westman E, Varrone A, Okamura N, Shimada H, Higuchi M, Halldin C, Nordberg A. Chiotis K, et al. Eur J Nucl Med Mol Imaging. 2018 Jul;45(9):1605-1617. doi: 10.1007/s00259-018-4012-5. Epub 2018 May 12. Eur J Nucl Med Mol Imaging. 2018. PMID: 29752516 Free PMC article.

5

In vivo visualization of tau deposits in corticobasal syndrome by 18F-THK5351 PET.

Kikuchi A, Okamura N, Hasegawa T, Harada R, Watanuki S, Funaki Y, Hiraoka K, Baba T, Sugeno N, Oshima R, Yoshida S, Kobayashi J, Ezura M, Kobayashi M, Tano O, Mugikura S, Iwata R, Ishiki A, Furukawa K, Arai H, Furumoto S, Tashiro M, Yanai K, Kudo Y, Takeda A, Aoki M. Kikuchi A, et al. Neurology. 2016 Nov 29;87(22):2309-2316. doi: 10.1212/WNL.0000000000003375. Epub 2016 Oct 28. Neurology. 2016. PMID: 27794115 Free PMC article.

6

Tau positron emission tomography using [¹⁸F]THK5351 and cerebral glucose hypometabolism in Alzheimer's disease.

Kang JM, Lee SY, Seo S, Jeong HJ, Woo SH, Lee H, Lee YB, Yeon BK, Shin DH, Park KH, Kang H, Okamura N, Furumoto S, Yanai K, Villemagne VL, Seong JK, Na DL, Ido T, Cho J, Lee KM, Noh Y. Kang JM, et al. Neurobiol Aging. 2017 Nov;59:210-219. doi: 10.1016/j.neurobiolaging.2017.08.008. Epub 2017 Aug 12. Neurobiol Aging. 2017. PMID: 28890300

7

First-in-Humans Evaluation of ¹⁸F-SMBT-1, a Novel ¹⁸F-Labeled Monoamine Oxidase-B PET Tracer for Imaging Reactive Astrogliosis.

Villemagne VL, Harada R, Doré V, Furumoto S, Mulligan R, Kudo Y, Burnham S, Krishnadas N, Bozinovski S, Huang K, Lopresti BJ, Yanai K, Rowe CC, Okamura N. Villemagne VL, et al. J Nucl Med. 2022 Oct;63(10):1551-1559. doi: 10.2967/jnumed.121.263254. Epub 2022 Jan 27. J Nucl Med. 2022. PMID: 35086898 Free PMC article.

8

18F-THK5351: A Novel PET Radiotracer for Imaging Neurofibrillary Pathology in Alzheimer Disease.

Harada R, Okamura N, Furumoto S, Furukawa K, Ishiki A, Tomita N, Tago T, Hiraoka K, Watanuki S, Shidahara M, Miyake M, Ishikawa Y, Matsuda R, Inami A, Yoshikawa T, Funaki Y, Iwata R, Tashiro M, Yanai K, Arai H, Kudo Y. Harada R, et al. J Nucl Med. 2016 Feb;57(2):208-14. doi: 10.2967/jnumed.115.164848. Epub 2015 Nov 5. J Nucl Med. 2016. PMID: 26541774 Free article.

9

Rasagiline, a monoamine oxidase B inhibitor, reduces in vivo [¹⁸F]THK5351 uptake in progressive supranuclear palsy.

Ng KP, Therriault J, Kang MS, Struyfs H, Pascoal TA, Mathotaarachchi S, Shin M, Benedet AL, Massarweh G, Soucy JP, Rosa-Neto P, Gauthier S. Ng KP, et al. Neuroimage Clin. 2019;24:102091. doi: 10.1016/j.nicl.2019.102091. Epub 2019 Nov 13. Neuroimage Clin. 2019. PMID: 31795034 Free PMC article.

10

Combination of Astrogliosis and Phosphorylated Tau for the Preclinical Diagnosis of Alzheimer Disease Using 3-Dimensional Stereotactic Surface Projection Images With 18 F-THK5351.

Imabayashi E, Saitoh Y, Tsukamoto T, Sakata M, Takano H. Imabayashi E, et al. Clin Nucl Med. 2022 Dec 1;47(12):1066-1068. doi: 10.1097/RLU.0000000000004425. Epub 2022 Sep 30. Clin Nucl Med. 2022. PMID: 36179331

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

144 results

Results by year